333 related articles for article (PubMed ID: 36430892)
21. Vasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review.
Japundžić-Žigon N; Lozić M; Šarenac O; Murphy D
Curr Neuropharmacol; 2020; 18(1):14-33. PubMed ID: 31544693
[TBL] [Abstract][Full Text] [Related]
22. VASCULAR RESPONSE TO POLYPEPTIDES IN ADRENAL-REGENERATION HYPERTENSION.
GARDNER DL; HONORE LH
Arch Int Pharmacodyn Ther; 1964 Aug; 150():492-503. PubMed ID: 14203128
[No Abstract] [Full Text] [Related]
23. Clinical studies with a vascular vasopressin antagonist.
Waeber B; Nussberger J; Hofbauer KG; Nicod P; Brunner HR
J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S111-6. PubMed ID: 2434764
[TBL] [Abstract][Full Text] [Related]
24. Role of vasopressin in clinical hypertension and congestive cardiac failure: interaction with the sympathetic nervous system.
Gavras H
Clin Chem; 1991 Oct; 37(10 Pt 2):1828-30. PubMed ID: 1914197
[TBL] [Abstract][Full Text] [Related]
25. STIMULANT ACTION OF ACTH AND RELATED POLYPEPTIDES ON SPONTANEOUS RHYTHMIC ACTIVITY OF ISOLATED HEART MUSCLE CELLS IN VITRO.
WOLENBERGER A; HALLE W
Fed Proc Transl Suppl; 1964; 23():1215-8. PubMed ID: 14209844
[No Abstract] [Full Text] [Related]
26. [ACTIVITY OF SOME POLYPEPTIDES ON THE RAT UTERUS IN SITU].
BIANCHINI P
Arch Ital Sci Farmacol; 1963 Apr; 13():149-50. PubMed ID: 14245124
[No Abstract] [Full Text] [Related]
27. Vasopressin and oxytocin receptors on plasma membranes from rat mammary gland. Demonstration of vasopressin receptors by stimulation of inositol phosphate formation, and oxytocin receptors by binding of a specific 125I-labeled oxytocin antagonist, d(CH2)5(1)[Tyr(Me)2, Thr4,Tyr-NH2(9)]OVT.
Soloff MS; Fernström MA; Fernström MJ
Biochem Cell Biol; 1989; 67(2-3):152-62. PubMed ID: 2546575
[TBL] [Abstract][Full Text] [Related]
28. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
29. DIFFERENTIAL DIALYSIS.
CRAIG LC
Science; 1964 May; 144(3622):1093-9. PubMed ID: 14148428
[No Abstract] [Full Text] [Related]
30. Vasopressin reduces release from vasopressin-neurons and oxytocin-neurons by acting on V2-like receptors.
Cheng SW; North WG
Brain Res; 1989 Feb; 479(1):35-9. PubMed ID: 2522339
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats.
Diamant M; De Wied D
Am J Physiol; 1993 Jan; 264(1 Pt 2):R51-61. PubMed ID: 8430886
[TBL] [Abstract][Full Text] [Related]
32. EFFECTS OF ALPHA-AND BETA-MELANOCYTE STIMULATING HORMONES AND OTHER PEPTIDES ON THE THYROID IN MICE.
BOWERS CY; REDDING TW; SCHALLY AV
Endocrinology; 1964 Apr; 74():559-66. PubMed ID: 14180149
[No Abstract] [Full Text] [Related]
33. [ACTIVITY OF SOME POLYPEPTIDES ON THE RAT UTERUS IN SITU].
BIANCHINI P
Farmaco Sci; 1963 Oct; 18():773-9. PubMed ID: 14113064
[No Abstract] [Full Text] [Related]
34. Copeptin: a biomarker of cardiovascular and renal function.
Morgenthaler NG
Congest Heart Fail; 2010 Jul; 16 Suppl 1():S37-44. PubMed ID: 20653710
[TBL] [Abstract][Full Text] [Related]
35. Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats.
Hicks C; Ramos L; Reekie T; Misagh GH; Narlawar R; Kassiou M; McGregor IS
Br J Pharmacol; 2014 Jun; 171(11):2868-87. PubMed ID: 24641248
[TBL] [Abstract][Full Text] [Related]
36. Vasopressin and oxytocin in genetically hypertensive rats of the Lyon strain.
Gauquelin G; Gharib C; Vincent M; Allevard AM; Semporé B; Benzoni D; Sassard J
J Cardiovasc Pharmacol; 1984; 6(1):94-8. PubMed ID: 6199619
[TBL] [Abstract][Full Text] [Related]
37. Haemodynamic effects of arginine-vasopressin microinjections into the nucleus tractus solitarius: a comparative study of vasopressin, a selective vasopressin receptor agonist and antagonist, and oxytocin.
Vallejo M; Carter DA; Lightman SL
Neurosci Lett; 1984 Dec; 52(3):247-52. PubMed ID: 6521969
[TBL] [Abstract][Full Text] [Related]
38. Discovery of novel selective hypotensive vasopressin peptides that exhibit little or no functional interactions with known oxytocin/vasopressin receptors.
Chan WY; Wo NC; Stoev S; Cheng LL; Manning M
Br J Pharmacol; 1998 Oct; 125(4):803-11. PubMed ID: 9831918
[TBL] [Abstract][Full Text] [Related]
39. Estradiol potentiates hypothalamic vasopressin and oxytocin neuron activation and hormonal secretion induced by hypovolemic shock.
Mecawi AS; Vilhena-Franco T; Araujo IG; Reis LC; Elias LL; Antunes-Rodrigues J
Am J Physiol Regul Integr Comp Physiol; 2011 Oct; 301(4):R905-15. PubMed ID: 21632848
[TBL] [Abstract][Full Text] [Related]
40. Vasopressin and oxytocin. Their presence in the central nervous system and their functional significance in brain processes related to behaviour and memory.
van Wimersma Greidanus TB; Burbach JP; Veldhuis HD
Acta Endocrinol Suppl (Copenh); 1986; 276():85-94. PubMed ID: 3463110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
